Merck CEO Says He’s Confident in Future Beyond Keytruda Patent Protection
CEO Robert Davis cites clinical and commercial progress across multiple therapeutic areas and greater visibility into the company's emerging product portfolio.
Related stories
Nikkei Index Falls 3%
M impact | EQUITY | Oct 30, 2026, 01:54 AM UTC
Chongqing Gas Q3 Net Profit Falls 88.27% Year Over Year
Chongqing Gas reported an 88.27% year-over-year decline in net profit for the first three quarters.
M impact | EQUITY | Oct 30, 2026, 01:54 AM UTC
AIA Shares Hit 4-week High
AIA shares increased to 74.10 HKD, the highest since September 2026. Over the past 4 weeks, AIA Group gained 6.58%, and in the last 12 months, it decreased 2.25%.
L impact | EQUITY | Oct 30, 2026, 01:53 AM UTC
Japan's Nikkei average falls 3%
M impact | EQUITY | Oct 30, 2026, 01:53 AM UTC
Japan’s Nikkei average down 3%
M impact | EQUITY | Oct 30, 2026, 01:53 AM UTC
Reddit Shares Plunge 18% After Revenue Outlook Misses Expectations
Reddit shares fell about 18% in after-hours trading in New York after the company said it would limit unregistered users’ access to its platform and issued a revenue outlook below
M impact | EQUITY | Oct 30, 2026, 01:51 AM UTC